Merck Balance Sheet Health
Financial Health criteria checks 4/6
Merck has a total shareholder equity of $44.6B and total debt of $38.1B, which brings its debt-to-equity ratio to 85.6%. Its total assets and total liabilities are $117.5B and $73.0B respectively. Merck's EBIT is $18.9B making its interest coverage ratio 20.7. It has cash and short-term investments of $14.6B.
Key information
85.6%
Debt to equity ratio
US$38.13b
Debt
| Interest coverage ratio | 20.7x |
| Cash | US$14.59b |
| Equity | US$44.56b |
| Total liabilities | US$72.97b |
| Total assets | US$117.53b |
Recent financial health updates
No updates
Recent updates
The Strong Earnings Posted By Merck (NYSE:MRK) Are A Good Indication Of The Strength Of The Business
Nov 15
Merck: Keytruda's Sales Projections Outweigh Competitive And Patent Risks
Nov 14Merck: An Undervalued Dividend Machine
Nov 07Merck Q3 Earnings Review: Solid Financials May Be Undermined By New Keytruda Threat
Oct 25Market Still Lacking Some Conviction On Merck & Co., Inc. (NYSE:MRK)
Oct 15Merck Is At Support And Should Go Higher (Technical Analysis)
Oct 07Merck Appears Ready To Return To June Highs (Technical Analysis)
Sep 14Merck's Change To Profit Guidance Provides An Opportunity
Sep 01Financial Position Analysis
Short Term Liabilities: MRK's short term assets ($40.4B) exceed its short term liabilities ($29.6B).
Long Term Liabilities: MRK's short term assets ($40.4B) do not cover its long term liabilities ($43.4B).
Debt to Equity History and Analysis
Debt Level: MRK's net debt to equity ratio (52.8%) is considered high.
Reducing Debt: MRK's debt to equity ratio has reduced from 96.9% to 85.6% over the past 5 years.
Debt Coverage: MRK's debt is well covered by operating cash flow (47.9%).
Interest Coverage: MRK's interest payments on its debt are well covered by EBIT (20.7x coverage).